Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by slaveonfoolson Aug 31, 2013 8:25am
205 Views
Post# 21711380

RE:Hi guys

RE:Hi guys
Some of those questions are a little hard to answer...

1) The company isnt saying how much their first payment will be from Wanbang which is smart as you dont want to give companies any leverage in future licensing deals...Im not sure when either.

2) Havetn heard anything but you could try calling company on that one. Sirona is usually pretty good at keeping us informed so im sure we will hear about it when it does happen

3) There has been no deals signed in regards to skin lightener being taken to commerialization so revenues are still a ways away. SIrona has always boasted that the skin lightenr is quick to market though so once a deal is in place, the ball should start rolling quickly. And they have TWO skin lightener compounds, both of which out perform the current market leader...

4) This is one area of concern...Theyve only got cash for a few more months but as we dont know how much they will (or have) received from Wangbang it is a grey area... They get funding for their travel by Canadian trade commisions, they get a grant form French government for Skin lightener studies , and now WangBang is fronting the bill for the rest of the SGLT2 studies and hopefully commerlization if all goes well. So we are not too sure on the current financials of SBM...

With more deals rumoured by end of year I am hoping that we wont need to see another PP here but we may be instore for one more as soem have posted...It all depends on how much they received from Wangbang and how much longer to skin lightener licensing deal...

Good Luck and Welcome aboard!

db
Bullboard Posts